Lars Skriver

4.8k citations

31 papers · 4.2k indexed · 1 hit paper · h-index 21

Impact in

Cancer Research top 0.2%
- Protease and Inhibitor Mechanisms
Hematology top 0.5%
- Blood Coagulation and Thrombosis Mechanisms

Papers in

Cancer Research 15
- Protease and Inhibitor Mechanisms 13
Biotechnology 5
- Enzyme Production and Characterization 5

Co-authors: Keld Danø Lene Nielsen J Grøndahl-Hansen P.A. Andreasen Peter Lommer Kristensen Lars S. Nielsen Guy A. Thompson Peter Kristensen
Journals: Biochemistry (3 papers)The Journal of Cell Biology (2 papers)FEBS Letters (2 papers)The EMBO Journal (2 papers)Journal of Biological Chemistry (2 papers)
Partner nations: Denmark United States Australia

In The Last Decade

Lars Skriver

31 papers receiving 4.0k citations

Hit Papers

align trajectories log scale

Plasminogen Activators, Tissue Degradation, and Cancer 1985 · 2.3k citations

Peers

Countries citing papers authored by Lars Skriver

Since Specialization

Citations

This map shows the geographic impact of Lars Skriver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Skriver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Skriver more than expected).

Fields of papers citing papers by Lars Skriver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Skriver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Skriver. The network helps show where Lars Skriver may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lars Skriver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lars Skriver Line = papers co-authored together Lars Skriver links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Monitoring process-related impurities in biologics–host cell protein analysis Analytical and Bioanalytical Chemistry ·Katrine Pilely, Andreas Abecker, Rikke Raaen Lund, Thomas Kofoed, Álvaro Andrés, Lars Skriver, Ejvind Mørtz	2021	39
2	A novel approach to evaluate ELISA antibody coverage of host cell proteins—combining ELISA‐based immunocapture and mass spectrometry Biotechnology Progress ·Katrine Pilely, A. Wittemann, Anette Holck Draborg, Maiken L. Henriksen, Søren Hansen, Lars Skriver, Ejvind Mørtz, Rikke Raaen Lund	2020	18
3	Sample pre-treatment determines the clinical usefulness of acid-labile subunit immunoassays in the diagnosis of growth hormone deficiency and acromegaly European Journal of Endocrinology ·Katherine M. Morrison, Martin Bidlingmaier, Hélio Dos Anjos, Zida Wu, Lars Skriver, Christian J. Strasburger	2007	10
4	Stabilization of Recombinantly Expressed Proteins Annals of the New York Academy of Sciences ·Finn Matthiesen, Kim R. Hejnæs, Lars Skriver	1996	2
5	A simple, rapid immunometric assay for determination of functional and growth hormone‐occupied growth hormone‐binding protein in human serum European Journal of Clinical Investigation ·Sanne Fisker, Jan Frystyk, Lars Skriver, E. Vestbo, Ken K. Y. Ho, Hans Ørskov	1996	61
6	Altered Ligand Specificity of Proteolyzed Insulin-like Growth Factor Binding Protein-3 Biochemical and Biophysical Research Communications ·Robert C. Baxter, Lars Skriver	1993	27
7	Characterization of the three 125I-iodination isomers of human insulin-like growth factor I (IGF1) Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·Federica Albanese, U. D. Larsen, Susanne Linde, Kim R. Hejnæs, Lars Skriver	1993	15
8	Development of an optimized refolding process for recombinant Ala–Glu–IGF-1 Protein Engineering Design and Selection ·Kim R. Hejnæs, 豊一郎信貴, Thomas Henning, Chao Li, Thi Thuy Linh Trinh, Johannes Thomsen, Lauge Schäffer, Axel Wollmer, Lars Skriver	1992	23
9	Primary sequences of insulin-like growth factors 1 and 2 isolated from porcine plasma Journal of Chromatography B Biomedical Sciences and Applications ·豊一郎信貴, C. M. Hoogerbrugge, Johannes Thomsen, Lars Skriver, S. C. van Buul-Offers, J. L. Van den Brande	1991	1
10	Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme. Journal of Biological Chemistry ·P.A. Andreasen, Lene Nielsen, Peter Kristensen, J Grøndahl-Hansen, Lars Skriver, Keld Danø	1986	208
11	Enzyme-Linked Immunosorbent Assay for Human Urokinase-Type Plasminogen Activator and its Proenzyme Using a Combination of Monoclonal and Polyclonal Antibodies Journal of Immunoassay ·Lars S. Nielsen, 周正凯, Peter A. Andreasen, Lars Skriver, Jesper Zeuthen, Сергій Михайлович Чевдар	1986	42
12	Plasminogen Activators, Tissue Degradation, and Cancer Advances in cancer research ·Keld Danø, P.A. Andreasen, J Grøndahl-Hansen, Peter Lommer Kristensen, Lene Nielsen, Lars Skriver Hit paper breakdown →	1985	2301
13	Inactive proenzyme to tissue-type plasminogen activator from human melanoma cells, identified after affinity purification with a monoclonal antibody. The EMBO Journal ·P.A. Andreasen, Lene Nielsen, J Grøndahl-Hansen, Lars Skriver, Jesper Zeuthen, Ross W. Stephens, Keld Danø	1984	71
14	Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma. The Journal of Cell Biology ·Lars Skriver, Lars Larsson, Elaf Al Adhreai, Lene Nielsen, Tianhua Lu, Peter Lund Kristensen, Keld Danø	1984	154
15	Monoclonal antibody to human 66,000 molecular weight plasminogen activator from melanoma cells. Specific enzyme inhibition and one-step affinity purification. The EMBO Journal ·Lene Nielsen, Kazuhide Shirai, P.A. Andreasen, Lars Skriver, Keld Danø, Jesper Zeuthen	1983	58
16	[Biochemical mechanism for extracellular proteolysis. Tissue destruction and cancer]. PubMed ·Lars Skriver, 秀男洲脇, Peter Kristensen, Keld Danø	1983	2
17	Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody Biochemistry ·Lars S. Nielsen, Kazuhide Shirai, Lars Skriver, Elaine Wilson, Keld Kaltoft, Jesper Zeuthen, Julienne Mcgeough	1982	220
18	Plasminogen Activator Released as Inactive Proenzyme from Murine Cells Transformed by Sarcoma Virus European Journal of Biochemistry ·Lars Skriver, Lars S. Nielsen, Ross W. Stephens, Keld Danø	1982	93
19	Regeneration of cilia in starved Tetrahymena thermophila involves induced synthesis of ciliary proteins but not synthesis of membrane lipids Biochemical Journal ·Lars Skriver, Norman E. Williams	1980	18
20	Cytoskeletal proteins of the cell surface in Tetrahymena Experimental Cell Research ·Norman E. Williams, Pierre Vaudaux, Lars Skriver	1979	72

About Lars Skriver

Lars Skriver is a scholar working on Cancer Research, Biotechnology, Immunology and Allergy, Endocrinology, Diabetes and Metabolism and Biochemistry, having authored 31 papers that have together received 4.2k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (13 papers), Peptidase Inhibition and Analysis (7 papers), Growth Hormone and Insulin-like Growth Factors (7 papers), Enzyme Production and Characterization (5 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Protist diversity and phylogeny (3 papers), Lipid Membrane Structure and Behavior (3 papers) and Lipid metabolism and biosynthesis (3 papers). The work is most often cited by research in Cancer Research (3.0k citations), Hematology (1.7k citations), Immunology and Allergy (870 citations), Biotechnology (330 citations) and Oncology (1.0k citations). Lars Skriver has collaborated with scholars based in Denmark, United States and Australia. Frequent co-authors include Keld Danø, Lene Nielsen, J Grøndahl-Hansen, P.A. Andreasen, Peter Lommer Kristensen, Lars S. Nielsen, Guy A. Thompson, Peter Kristensen, Jesper Zeuthen and Lars Larsson. Their work appears in journals such as Biochemistry, The Journal of Cell Biology, FEBS Letters, The EMBO Journal and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact